Classic Hodgkin lymphoma in young people

Classic Hodgkin lymphoma (CHL) is a unique form of lymphoid cancer featuring a heterogeneous tumor microenvironment and a relative paucity of malignant Hodgkin and Reed-Sternberg (HRS) cells with characteristic phenotype. Younger individuals (children, adolescents and young adults) are affected as o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Seminars in diagnostic pathology 2023-11, Vol.40 (6), p.379-391
Hauptverfasser: Gupta, Srishti, Craig, Jeffrey W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 391
container_issue 6
container_start_page 379
container_title Seminars in diagnostic pathology
container_volume 40
creator Gupta, Srishti
Craig, Jeffrey W.
description Classic Hodgkin lymphoma (CHL) is a unique form of lymphoid cancer featuring a heterogeneous tumor microenvironment and a relative paucity of malignant Hodgkin and Reed-Sternberg (HRS) cells with characteristic phenotype. Younger individuals (children, adolescents and young adults) are affected as often as the elderly, producing a peculiar bimodal age-incidence profile that has generated immense interest in this disease and its origins. Decades of epidemiological investigations have documented the populations most susceptible and identified multiple risk factors that can be broadly categorized as either biological or environmental in nature. Most risk factors result in overt immunodeficiency or confer more subtle alterations to baseline health, physiology or immune function. Epstein Barr virus, however, is both a risk factor and well-established driver of lymphomagenesis in a significant subset of cases. Epigenetic changes, along with the accumulation of somatic driver mutations and cytogenetic abnormalities are required for the malignant transformation of germinal center-experienced HRS cell precursors. Chromosomal instability and the influence of endogenous mutational processes are critical in this regard, by impacting genes involved in key signaling pathways that promote the survival and proliferation of HRS cells and their escape from immune destruction. Here we review the principal features, known risk factors and lymphomagenic mechanisms relevant to newly diagnosed CHL, with an emphasis on those most applicable to young people.
doi_str_mv 10.1053/j.semdp.2023.06.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2838251824</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S074025702300076X</els_id><sourcerecordid>2838251824</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-d5b6b3dd9460fa1b246ac8bd5c70e82550ce1e3e8db441f6054b2cb3767e67713</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqXwC5BQxi4J5_grGRhQBRSpEgvMVmJfiksSh7hB6r8npYWRW-6G90P3EHJNIaEg2O0mCdjYLkkhZQnIBECckCnNGcR0nFMyBcUhToWCCbkIYQPAFND8nEyY4oLmnE3JfFEXITgTLb1df7g2qndN9-6bIhrvnR_addSh72q8JGdVUQe8Ou4ZeXt8eF0s49XL0_PifhUbBvk2tqKUJbM25xKqgpYpl4XJSiuMAsxSIcAgRYaZLTmnlQTBy9SUTEmFUinKZmR-yO16_zlg2OrGBYN1XbToh6DTjI0xNEv5KGUHqel9CD1WuutdU_Q7TUHvEemN_kGk94g0SD0iGl03x4KhbND-eX6ZjIK7gwDHN78c9joYh61B63o0W229-7fgGxZfdw4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2838251824</pqid></control><display><type>article</type><title>Classic Hodgkin lymphoma in young people</title><source>Elsevier ScienceDirect Journals</source><creator>Gupta, Srishti ; Craig, Jeffrey W.</creator><creatorcontrib>Gupta, Srishti ; Craig, Jeffrey W.</creatorcontrib><description>Classic Hodgkin lymphoma (CHL) is a unique form of lymphoid cancer featuring a heterogeneous tumor microenvironment and a relative paucity of malignant Hodgkin and Reed-Sternberg (HRS) cells with characteristic phenotype. Younger individuals (children, adolescents and young adults) are affected as often as the elderly, producing a peculiar bimodal age-incidence profile that has generated immense interest in this disease and its origins. Decades of epidemiological investigations have documented the populations most susceptible and identified multiple risk factors that can be broadly categorized as either biological or environmental in nature. Most risk factors result in overt immunodeficiency or confer more subtle alterations to baseline health, physiology or immune function. Epstein Barr virus, however, is both a risk factor and well-established driver of lymphomagenesis in a significant subset of cases. Epigenetic changes, along with the accumulation of somatic driver mutations and cytogenetic abnormalities are required for the malignant transformation of germinal center-experienced HRS cell precursors. Chromosomal instability and the influence of endogenous mutational processes are critical in this regard, by impacting genes involved in key signaling pathways that promote the survival and proliferation of HRS cells and their escape from immune destruction. Here we review the principal features, known risk factors and lymphomagenic mechanisms relevant to newly diagnosed CHL, with an emphasis on those most applicable to young people.</description><identifier>ISSN: 0740-2570</identifier><identifier>EISSN: 1930-1111</identifier><identifier>DOI: 10.1053/j.semdp.2023.06.005</identifier><identifier>PMID: 37451943</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Epstein Barr virus ; Hodgkin lymphoma ; Mutational signature ; Pathogenesis ; Pediatric ; Risk factor</subject><ispartof>Seminars in diagnostic pathology, 2023-11, Vol.40 (6), p.379-391</ispartof><rights>2023</rights><rights>Copyright © 2023. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c309t-d5b6b3dd9460fa1b246ac8bd5c70e82550ce1e3e8db441f6054b2cb3767e67713</cites><orcidid>0000-0003-1295-3258</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S074025702300076X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37451943$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gupta, Srishti</creatorcontrib><creatorcontrib>Craig, Jeffrey W.</creatorcontrib><title>Classic Hodgkin lymphoma in young people</title><title>Seminars in diagnostic pathology</title><addtitle>Semin Diagn Pathol</addtitle><description>Classic Hodgkin lymphoma (CHL) is a unique form of lymphoid cancer featuring a heterogeneous tumor microenvironment and a relative paucity of malignant Hodgkin and Reed-Sternberg (HRS) cells with characteristic phenotype. Younger individuals (children, adolescents and young adults) are affected as often as the elderly, producing a peculiar bimodal age-incidence profile that has generated immense interest in this disease and its origins. Decades of epidemiological investigations have documented the populations most susceptible and identified multiple risk factors that can be broadly categorized as either biological or environmental in nature. Most risk factors result in overt immunodeficiency or confer more subtle alterations to baseline health, physiology or immune function. Epstein Barr virus, however, is both a risk factor and well-established driver of lymphomagenesis in a significant subset of cases. Epigenetic changes, along with the accumulation of somatic driver mutations and cytogenetic abnormalities are required for the malignant transformation of germinal center-experienced HRS cell precursors. Chromosomal instability and the influence of endogenous mutational processes are critical in this regard, by impacting genes involved in key signaling pathways that promote the survival and proliferation of HRS cells and their escape from immune destruction. Here we review the principal features, known risk factors and lymphomagenic mechanisms relevant to newly diagnosed CHL, with an emphasis on those most applicable to young people.</description><subject>Epstein Barr virus</subject><subject>Hodgkin lymphoma</subject><subject>Mutational signature</subject><subject>Pathogenesis</subject><subject>Pediatric</subject><subject>Risk factor</subject><issn>0740-2570</issn><issn>1930-1111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAQhi0EoqXwC5BQxi4J5_grGRhQBRSpEgvMVmJfiksSh7hB6r8npYWRW-6G90P3EHJNIaEg2O0mCdjYLkkhZQnIBECckCnNGcR0nFMyBcUhToWCCbkIYQPAFND8nEyY4oLmnE3JfFEXITgTLb1df7g2qndN9-6bIhrvnR_addSh72q8JGdVUQe8Ou4ZeXt8eF0s49XL0_PifhUbBvk2tqKUJbM25xKqgpYpl4XJSiuMAsxSIcAgRYaZLTmnlQTBy9SUTEmFUinKZmR-yO16_zlg2OrGBYN1XbToh6DTjI0xNEv5KGUHqel9CD1WuutdU_Q7TUHvEemN_kGk94g0SD0iGl03x4KhbND-eX6ZjIK7gwDHN78c9joYh61B63o0W229-7fgGxZfdw4</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Gupta, Srishti</creator><creator>Craig, Jeffrey W.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1295-3258</orcidid></search><sort><creationdate>20231101</creationdate><title>Classic Hodgkin lymphoma in young people</title><author>Gupta, Srishti ; Craig, Jeffrey W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-d5b6b3dd9460fa1b246ac8bd5c70e82550ce1e3e8db441f6054b2cb3767e67713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Epstein Barr virus</topic><topic>Hodgkin lymphoma</topic><topic>Mutational signature</topic><topic>Pathogenesis</topic><topic>Pediatric</topic><topic>Risk factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gupta, Srishti</creatorcontrib><creatorcontrib>Craig, Jeffrey W.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in diagnostic pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gupta, Srishti</au><au>Craig, Jeffrey W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Classic Hodgkin lymphoma in young people</atitle><jtitle>Seminars in diagnostic pathology</jtitle><addtitle>Semin Diagn Pathol</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>40</volume><issue>6</issue><spage>379</spage><epage>391</epage><pages>379-391</pages><issn>0740-2570</issn><eissn>1930-1111</eissn><abstract>Classic Hodgkin lymphoma (CHL) is a unique form of lymphoid cancer featuring a heterogeneous tumor microenvironment and a relative paucity of malignant Hodgkin and Reed-Sternberg (HRS) cells with characteristic phenotype. Younger individuals (children, adolescents and young adults) are affected as often as the elderly, producing a peculiar bimodal age-incidence profile that has generated immense interest in this disease and its origins. Decades of epidemiological investigations have documented the populations most susceptible and identified multiple risk factors that can be broadly categorized as either biological or environmental in nature. Most risk factors result in overt immunodeficiency or confer more subtle alterations to baseline health, physiology or immune function. Epstein Barr virus, however, is both a risk factor and well-established driver of lymphomagenesis in a significant subset of cases. Epigenetic changes, along with the accumulation of somatic driver mutations and cytogenetic abnormalities are required for the malignant transformation of germinal center-experienced HRS cell precursors. Chromosomal instability and the influence of endogenous mutational processes are critical in this regard, by impacting genes involved in key signaling pathways that promote the survival and proliferation of HRS cells and their escape from immune destruction. Here we review the principal features, known risk factors and lymphomagenic mechanisms relevant to newly diagnosed CHL, with an emphasis on those most applicable to young people.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37451943</pmid><doi>10.1053/j.semdp.2023.06.005</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-1295-3258</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0740-2570
ispartof Seminars in diagnostic pathology, 2023-11, Vol.40 (6), p.379-391
issn 0740-2570
1930-1111
language eng
recordid cdi_proquest_miscellaneous_2838251824
source Elsevier ScienceDirect Journals
subjects Epstein Barr virus
Hodgkin lymphoma
Mutational signature
Pathogenesis
Pediatric
Risk factor
title Classic Hodgkin lymphoma in young people
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A35%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Classic%20Hodgkin%20lymphoma%20in%20young%20people&rft.jtitle=Seminars%20in%20diagnostic%20pathology&rft.au=Gupta,%20Srishti&rft.date=2023-11-01&rft.volume=40&rft.issue=6&rft.spage=379&rft.epage=391&rft.pages=379-391&rft.issn=0740-2570&rft.eissn=1930-1111&rft_id=info:doi/10.1053/j.semdp.2023.06.005&rft_dat=%3Cproquest_cross%3E2838251824%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2838251824&rft_id=info:pmid/37451943&rft_els_id=S074025702300076X&rfr_iscdi=true